Skip to main content
HYUNDAI BIOSCIENCE CO., LTD. logo

HYUNDAI BIOSCIENCE CO., LTD. — Investor Relations & Filings

Ticker · 048410 ISIN · KR7048410005 KO Professional, scientific and technical activities
Open in API
Filings indexed 289 across all filing types
Latest filing 2026-05-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 048410

About HYUNDAI BIOSCIENCE CO., LTD.

http://www.hyundaibioscience.com/eindex…

HYUNDAI BIOSCIENCE CO., LTD. is a biotechnology company focused on developing innovative therapeutics using its proprietary drug delivery system (DDS) technology. The company's core science is based on organic-inorganic hybrid technologies designed to safely and effectively deliver active ingredients. Its main development pipeline includes CP-COV03, a broad-spectrum antiviral agent that enhances cellular autophagy to combat viral infections, and Polytaxel, an anticancer drug candidate developed with polymer transfer technologies to reduce toxicity. The company's primary focus is on creating novel treatments for viral diseases and cancer.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 98% confidence The document is a ‘주식등의 대량보유상황보고서(약식)’ – a Large Shareholding Status Report under Korea’s Capital Markets Act, detailing the number of shares held, changes in holdings, purchase/disposal dates and methods by Samsung Asset Management. This corresponds exactly to a Major Shareholding Notification.
2026-05-29 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제27기) 2026년 01월 01일–2026년 03월 31일” and contains detailed financial statements (연결재무제표, 재무제표), notes, management discussion, audit opinions, and quarter‐to‐date performance for the first quarter of fiscal year 2026. This is a full interim/quarterly report rather than a brief earnings release or announcement. Hence, it fits the definition of an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a Korean “주식등의 대량보유상황보고서(일반)” (Large Shareholding Status Report under the Capital Markets Act), detailing the number of shares held, percentage ownership, related party holdings, and contractual arrangements. This matches the definition of a major shareholding notification. Therefore, it should be classified as MRQ (Major Shareholding Notification).
2026-04-23 Korean
투자판단관련주요경영사항(임상시험계획변경승인) (전립선암 치료제 CPPCA07의 1상 임상시험계획 변경승인)
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure in Korean (“투자판단 관련 주요경영사항”) detailing a clinical trial plan change approval by the MFDS. It is not a financial report, earnings release, management change, or other specific categories like dividend or M&A. It is a general regulatory announcement about an important corporate matter for investors. Therefore, it best fits the fallback ’Regulatory Filings’ category (RNS).
2026-04-17 Korean
[기재정정]사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Hyundai Bioscience, which is the Korean equivalent of an Annual Report (10-K). It contains comprehensive financial statements, management discussion and analysis, governance information, and operational details for the fiscal year 2025. Although it includes a correction notice at the beginning, the document itself is the full annual filing. FY 2025
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is the official results of the regular shareholders’ meeting (정기주주총회결과), listing each agenda item with vote counts, approval status (가결/부결/미결), and voting percentages. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA). It is not merely a notice or retrospective publication, but the direct voting outcomes. Therefore, the correct classification is DVA.
2026-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.